80
Participants
Start Date
December 1, 2018
Primary Completion Date
September 30, 2020
Study Completion Date
September 30, 2020
BupreCare
"Subjects will receive their medication in a MedicaSafe device. Medication will be dispensed in accordance with the programmed treatment plan for each subject. Subjects will complete a Check-In remotely each week with their device."
Buprenorphine/naloxone
Subjects will be given buprenorphine/naloxone as a component of Medication Assisted Treatment (MAT).
MEMS
Subjects will receive their medication in a MEMS pill bottle.
RECRUITING
Friends Research Institute, Baltimore
TERMINATED
Artemis Institute for Clinical Research, San Diego
Collaborators (1)
Friends Research Institute, Inc.
OTHER
MedicaSafe, Inc.
INDUSTRY